The APULEIO study showed that apixaban per se or as a component of an optimized medical therapy is useful to reach a positive impact on depressive symptoms in frail and disabled patients, and on HRQL in disabled subjects.
Apixaban and the improved psychologic profile in frailty and disability. Myth or reality? / Fumagalli, Stefano; Di Pasquale, Giuseppe; Molon, Giulio; Agnelli, Giancarlo; Marchionni, Niccolò. - In: EUROPEAN JOURNAL OF INTERNAL MEDICINE. - ISSN 0953-6205. - ELETTRONICO. - (2025), pp. 1-2. [10.1016/j.ejim.2025.03.012]
Apixaban and the improved psychologic profile in frailty and disability. Myth or reality?
Fumagalli, Stefano
;Marchionni, Niccolò
2025
Abstract
The APULEIO study showed that apixaban per se or as a component of an optimized medical therapy is useful to reach a positive impact on depressive symptoms in frail and disabled patients, and on HRQL in disabled subjects.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0953620525000986-main.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
304.77 kB
Formato
Adobe PDF
|
304.77 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
